Lazurite moving toward FDA submission

Lazurite logo-agile technologies for optimal care

The company plans to submit its premarket notification later this year and expects to receive FDA approval to launch in the first half of 2022.

Click here to read the complete story.

Story excerpt provided by Crain’s Cleveland Business.

Written by Lydia Coutré.

Originally published August 8, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: